Fulgent Genetics Files DEF 14A on Executive Compensation
Ticker: FLGT · Form: DEF 14A · Filed: Mar 25, 2025 · CIK: 1674930
| Field | Detail |
|---|---|
| Company | Fulgent Genetics, Inc. (FLGT) |
| Form Type | DEF 14A |
| Filed Date | Mar 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, proxy-statement, corporate-governance
TL;DR
Fulgent Genetics DEF 14A out: Executive comp details for FY24, including equity awards.
AI Summary
Fulgent Genetics, Inc. filed a DEF 14A on March 25, 2025, detailing executive compensation and corporate governance matters for the fiscal year ending December 31, 2024. The filing includes information on equity awards granted to its principal executive officer and other named executive officers, with fair values calculated as of their respective grant dates and year-end. Specific details regarding the change in fair value of outstanding equity awards and those vesting during the covered year are also presented.
Why It Matters
This filing provides transparency into how Fulgent Genetics compensates its top executives, which can influence investor decisions and employee morale.
Risk Assessment
Risk Level: low — This is a routine filing providing information on executive compensation and corporate governance, with no immediate financial risks indicated.
Key Numbers
- 20250325 — Filing Date (Date the DEF 14A was filed with the SEC.)
- 2024-12-31 — Fiscal Year End (The end date of the fiscal year for which compensation information is reported.)
Key Players & Entities
- Fulgent Genetics, Inc. (company) — Filer
- 4399 SANTA ANITA AVE (address) — Business and Mail Address
- EL MONTE (city) — Business and Mail City
- CA (state) — Business and Mail State
- 91731 (zip_code) — Business and Mail Zip Code
- 626-350-0537 (phone_number) — Business Phone
- Fulgent Diagnostics, Inc. (company) — Former Company Name
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is filed by companies to solicit proxies from shareholders for their annual or special meetings, and it contains detailed information about executive compensation, board of directors, and other corporate governance matters.
When was Fulgent Genetics, Inc. incorporated?
Fulgent Genetics, Inc. was incorporated in Delaware (DE).
What was Fulgent Genetics, Inc.'s former company name?
Fulgent Genetics, Inc.'s former company name was Fulgent Diagnostics, Inc., with a date of name change on May 17, 2016.
What is the SIC code for Fulgent Genetics, Inc.?
The Standard Industrial Classification (SIC) code for Fulgent Genetics, Inc. is 8071, which falls under SERVICES-MEDICAL LABORATORIES.
What specific compensation-related data points are mentioned for the fiscal year ending December 31, 2024?
The filing mentions data points related to equity awards, including their fair value at grant date, year-end fair value of outstanding and unvested awards, changes in fair value, and awards vesting during the covered year, specifically for the period from January 1, 2024, to December 31, 2024.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on March 25, 2025 regarding Fulgent Genetics, Inc. (FLGT).